Trial Profile
A clinical study of IBIO-200 for COVID-19 infection
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs IBIO 200 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 03 Apr 2020 New trial record